transdermal ozone linked to notable drop in work impairment scores in fibromyalgia study
Ozone therapy significantly reduced work impairment VAS subscale scores in fibromyalgia patients from 63.9 at baseline to 44.1 at week 12 (p<0.0001), with a moderate-to-large effect size of 0.65.
What this means for you
When widespread muscle pain and fatigue make it hard to get through a workday, anything that reduces that burden matters. This finding showed a meaningful improvement in how much pain interfered with people's ability to function at work — a real-world measure most people with chronic discomfort care deeply about.
The published research
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.